Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment
収録刊行物
-
- European Journal of Cancer
-
European Journal of Cancer 47 (17), 2603-2606, 2011-11
Elsevier BV